Haynes and Boone Represents Alliqua in $29 Million Transaction

01/08/2018

Haynes and Boone, LLP represented Alliqua BioMedical, Inc. in a $29 million asset purchase agreement with Celularity, Inc., a transaction announced Jan. 5.

New York-based Partners Rick Werner and Greg Kramer and Associate Patrick Horan represented Alliqua, a regenerative technologies company with locations in Yardley, Pennsylvania, Langhorne, Pennsylvania and Eden Prairie, Minnesota.

The agreement, which is subject to stockholder approval, calls for Celularity to acquire all of the property, assets and rights relating to Alliqua’s advanced biologic wound care business — including Biovance® amniotic membrane allograft and Interfyl® Human Connective Tissue Matrix — and the company’s UltraMist® Therapy System and other therapeutic ultrasound platform products for an aggregate cash consideration of $29 million.

Alliqua’s announcement said the agreement includes all intellectual property and all license, marketing, development and supply agreements related to the businesses.

Media Contact

Nathan Koppel
Director of Media Relations
+1 512.867.8431
nathan.koppel@haynesboone.com

Email Disclaimer